North American ACE Inhibitors Market Set for Robust Growth, Led by Pharma Giants

Dublin, Tuesday, 12 November 2024.
The North American ACE inhibitors market, valued at $2.18 billion in 2023, is projected to reach $2.93 billion by 2029, growing at a CAGR of 5.25%. Pfizer, Novartis, and AstraZeneca lead this expansion, driven by an aging population and rising cardiovascular disease prevalence.